Oxford Immunotec Global PLC (NASDAQ:OXFD) announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, and Richard Altieri, Chief Financial Officer, will present at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8, 2016, at 9:20 a.m. EST at the Boston Marriott Copley Place in Boston, MA.
Oxford Immunotec Global PLC (NASDAQ:OXFD) belongs to Healthcare sector. Its net profit margin is -42.70% and weekly performance is -4.83%. On last trading day company shares ended up at $9.66. Oxford Immunotec Global PLC (NASDAQ:OXFD) distance from 50-day simple moving average (SMA50) is 2.99%.
On 22 February, Jaguar Animal Health, Inc. (NASDAQ:JAGX) announced the appointment of Philippe Brianceau, DVM, as chief veterinary officer, effective immediately.
Jaguar Animal Health, Inc. (NASDAQ:JAGX) shares moved down -7.61% in last trading session and ended the day at $1.82. JAGX Gross Margin is 50.00% and its return on assets is -148.70%. Jaguar Animal Health, Inc. (NASDAQ:JAGX) quarterly performance is -15.35%.
PTC Therapeutics, Inc. (NASDAQ:PTCT) announced that it received a Refuse to File letter from the United States Food and Drug Administration (FDA) regarding PTC’s New Drug Application (NDA) for Translarna (ataluren), an oral, first-in-class, protein restoration therapy for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD).
On 23 February, PTC Therapeutics, Inc. (NASDAQ:PTCT) shares moved down -61.64% and was closed at $10.84. PTCT EPS growth in last 5 year was -6.40%. PTC Therapeutics, Inc. (NASDAQ:PTCT) year to date (YTD) performance is -66.54%.
On 18 February, Oshkosh Corporation (NYSE:OSK) is clear of the legal challenge related to its Joint Light Tactical Vehicle (JLTV) production contract award after a competitor withdrew its protest from the U.S. Court of Federal Claims. Last week, the Court of Federal Claims denied the competitor’s request for a preliminary injunction, which allowed Oshkosh to continue work under the $6.7 billion JLTV contract. The JLTV program is cited among the Department of Defense’s top modernization priorities.
Oshkosh Corporation (NYSE:OSK) ended the last trading day at $33.71. Company weekly volatility is calculated as 3.38% and price to cash ratio as 73.13. Oshkosh Corporation (NYSE:OSK) showed a weekly performance of 0.69%.
KeyBanc reaffirmed their overweight rating on shares of Cirrus Logic, Inc. (NASDAQ:CRUS) in a research note published on Monday, MarketBeat Ratings reports. The firm currently has a $40.00 price target on the stock.
Cirrus Logic Inc. (NASDAQ:CRUS) shares moved down -2.23% in last trading session and ended the day at $33.72. CRUS Gross Margin is 46.80% and its return on assets is 10.90%. Cirrus Logic Inc. (NASDAQ:CRUS) quarterly performance is 17.21%.